873014-23-4

Upstream product

• 97-51-8 5-Nitrosalicylaldehyde 
• 132883-18-2 methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-β-D-galacto-non-2-ulopyranosyl chloride 
• 864933-92-6 methyl [2-O-(2-formyl-4-nitrophenyl)-5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-α-galacto-2-nonulopyranosid]onate 
• 864933-93-7 methyl {2-O-[2-(difluoromethyl)-4-nitrophenyl]-5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-α-D-galacto-2-nonulopyranosid}onate 

Downstream Products

• 873014-25-6 4-acetoxy-5-(acetylamino)-2-[2-(difluoromethyl)-4-(3-{6-[5-(2-oxohexahydrothieno[3,4-d]imidazol-6-yl)pentanoylamino]hexylcarbamoyl}propionylamino)phenoxy]-6-(1,2,3-triacetoxypropyl)tetrahydropyran-2-carboxylic acid methyl ester 
• 873014-24-5 4-acetoxy-5-(acetylamino)-2-{4-[(3-carboxypropionyl)amino]-2-(difluoromethyl)phenoxy}-6-(1,2,3-triacetoxypropyl)tetrahydropyran-2-carboxylic acid methyl ester 

Relevant academic research and scientific papers

Neuraminidase inhibitor

This invention relates to a method of treating an infection with an influenza virus. The method includes administering to a subject in need thereof an effective amount of a compound of formula (I): Each variable in this formula is defined in the specifica

Design of a mechanism-based probe for neuraminidase to capture influenza viruses

(Chemical Equation Presented) Getting a grip on the flu: A mechanism-based probe, 1, for neuraminidase was developed. It is capable of forming a biotinylated adduct with neuraminidase (NA) from Arthrobacter ureafaciens. It also displays an inhibitory effe